ArticleFrontiers in neurology2024

Clinical utility of plasma Aβ42/40 ratio by LC-MS/MS in Alzheimer's disease assessment.

Darren M Weber et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.